FDA approves drugs for cough, dysmenorrhea

02/28/2013 | RTT News

Hawthorn Pharmaceuticals gained federal approval for its VITUZ oral solution to treat cough and upper respiratory allergies in adults. Cypress Pharmaceuticals also received final approval for its mefenamic acid capsules USP, a generic version of Ponstel Capsules, to address mild-to-moderate pain with primary dysmenorrhea. Hawthorn and Cypress were subsidiaries of Pernix Therapeutics Holdings.

View Full Article in:

RTT News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ